Cross-Sex Hormone Treatment and Psychobiological Changes in Transsexual Persons: Two-Year Follow-Up Data

Context:To date, there are few studies investigating the impact of body changes induced by cross-sex hormonal treatment (CHT) on psychobiological well-being in gender-dysphoric persons (GDs).Objective:The objective of the study was to assess whether CHT-related body changes affect psychobiological w...

Full description

Saved in:
Bibliographic Details
Published inThe journal of clinical endocrinology and metabolism Vol. 101; no. 11; pp. 4260 - 4269
Main Authors Fisher, Alessandra D., Castellini, Giovanni, Ristori, Jiska, Casale, Helen, Cassioli, Emanuele, Sensi, Carolina, Fanni, Egidia, Amato, Anna Maria Letizia, Bettini, Eva, Mosconi, Maddalena, Dèttore, Davide, Ricca, Valdo, Maggi, Mario
Format Journal Article
LanguageEnglish
Published United States Oxford University Press 01.11.2016
Copyright by The Endocrine Society
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Context:To date, there are few studies investigating the impact of body changes induced by cross-sex hormonal treatment (CHT) on psychobiological well-being in gender-dysphoric persons (GDs).Objective:The objective of the study was to assess whether CHT-related body changes affect psychobiological well-being in GDs.Methods:A consecutive series of 359 GDs was considered for a cross-sectional section of the study. In addition, 54 GDs were studied in a 2-year follow-up. A physical examination was performed, including body mass index, waist circumference, and hair distribution. We also evaluated breast development and testis volume in male to female subjects and clitoris length in female to male. Subjects were asked to complete several psychometric measures for the assessment of body uneasiness, GD, and psychopathology levels. The evaluation was repeated 2 years prospectively.Results:The following results were found: 1) GDs undergoing CHT reported significantly lower subjective levels of GD, body uneasiness, and depressive symptoms as compared with those without; 2) CHT-induced body modifications were significantly associated with a better psychological adjustment; 3) during CHT, GDs reported a significant reduction of general psychopathology, depressive symptoms, and subjective GD, whereas social and legal indicators of GD showed a significant increase across time; and 4) among body changes induced by CHT, only breast development and increased body mass index had a significant impact on psychopathology reduction across time in male to female subjects and female to male subjects, respectively.Conclusions:The aforementioned results support the efficacy of CHT intervention in improving subjective perception of one’s own body, which was partially associated with objective changes.
AbstractList To date, there are few studies investigating the impact of body changes induced by cross-sex hormonal treatment (CHT) on psychobiological well-being in gender-dysphoric persons (GDs). The objective of the study was to assess whether CHT-related body changes affect psychobiological well-being in GDs. A consecutive series of 359 GDs was considered for a cross-sectional section of the study. In addition, 54 GDs were studied in a 2-year follow-up. A physical examination was performed, including body mass index, waist circumference, and hair distribution. We also evaluated breast development and testis volume in male to female subjects and clitoris length in female to male. Subjects were asked to complete several psychometric measures for the assessment of body uneasiness, GD, and psychopathology levels. The evaluation was repeated 2 years prospectively. The following results were found: 1) GDs undergoing CHT reported significantly lower subjective levels of GD, body uneasiness, and depressive symptoms as compared with those without; 2) CHT-induced body modifications were significantly associated with a better psychological adjustment; 3) during CHT, GDs reported a significant reduction of general psychopathology, depressive symptoms, and subjective GD, whereas social and legal indicators of GD showed a significant increase across time; and 4) among body changes induced by CHT, only breast development and increased body mass index had a significant impact on psychopathology reduction across time in male to female subjects and female to male subjects, respectively. The aforementioned results support the efficacy of CHT intervention in improving subjective perception of one's own body, which was partially associated with objective changes.
Context:To date, there are few studies investigating the impact of body changes induced by cross-sex hormonal treatment (CHT) on psychobiological well-being in gender-dysphoric persons (GDs).Objective:The objective of the study was to assess whether CHT-related body changes affect psychobiological well-being in GDs.Methods:A consecutive series of 359 GDs was considered for a cross-sectional section of the study. In addition, 54 GDs were studied in a 2-year follow-up. A physical examination was performed, including body mass index, waist circumference, and hair distribution. We also evaluated breast development and testis volume in male to female subjects and clitoris length in female to male. Subjects were asked to complete several psychometric measures for the assessment of body uneasiness, GD, and psychopathology levels. The evaluation was repeated 2 years prospectively.Results:The following results were found: 1) GDs undergoing CHT reported significantly lower subjective levels of GD, body uneasiness, and depressive symptoms as compared with those without; 2) CHT-induced body modifications were significantly associated with a better psychological adjustment; 3) during CHT, GDs reported a significant reduction of general psychopathology, depressive symptoms, and subjective GD, whereas social and legal indicators of GD showed a significant increase across time; and 4) among body changes induced by CHT, only breast development and increased body mass index had a significant impact on psychopathology reduction across time in male to female subjects and female to male subjects, respectively.Conclusions:The aforementioned results support the efficacy of CHT intervention in improving subjective perception of one’s own body, which was partially associated with objective changes.
CONTEXTTo date, there are few studies investigating the impact of body changes induced by cross-sex hormonal treatment (CHT) on psychobiological well-being in gender-dysphoric persons (GDs).OBJECTIVEThe objective of the study was to assess whether CHT-related body changes affect psychobiological well-being in GDs.METHODSA consecutive series of 359 GDs was considered for a cross-sectional section of the study. In addition, 54 GDs were studied in a 2-year follow-up. A physical examination was performed, including body mass index, waist circumference, and hair distribution. We also evaluated breast development and testis volume in male to female subjects and clitoris length in female to male. Subjects were asked to complete several psychometric measures for the assessment of body uneasiness, GD, and psychopathology levels. The evaluation was repeated 2 years prospectively.RESULTSThe following results were found: 1) GDs undergoing CHT reported significantly lower subjective levels of GD, body uneasiness, and depressive symptoms as compared with those without; 2) CHT-induced body modifications were significantly associated with a better psychological adjustment; 3) during CHT, GDs reported a significant reduction of general psychopathology, depressive symptoms, and subjective GD, whereas social and legal indicators of GD showed a significant increase across time; and 4) among body changes induced by CHT, only breast development and increased body mass index had a significant impact on psychopathology reduction across time in male to female subjects and female to male subjects, respectively.CONCLUSIONSThe aforementioned results support the efficacy of CHT intervention in improving subjective perception of one's own body, which was partially associated with objective changes.
CONTEXT:To date, there are few studies investigating the impact of body changes induced by cross-sex hormonal treatment (CHT) on psychobiological well-being in gender-dysphoric persons (GDs). OBJECTIVE:The objective of the study was to assess whether CHT-related body changes affect psychobiological well-being in GDs. METHODS:A consecutive series of 359 GDs was considered for a cross-sectional section of the study. In addition, 54 GDs were studied in a 2-year follow-up. A physical examination was performed, including body mass index, waist circumference, and hair distribution. We also evaluated breast development and testis volume in male to female subjects and clitoris length in female to male. Subjects were asked to complete several psychometric measures for the assessment of body uneasiness, GD, and psychopathology levels. The evaluation was repeated 2 years prospectively. RESULTS:The following results were found1) GDs undergoing CHT reported significantly lower subjective levels of GD, body uneasiness, and depressive symptoms as compared with those without; 2) CHT-induced body modifications were significantly associated with a better psychological adjustment; 3) during CHT, GDs reported a significant reduction of general psychopathology, depressive symptoms, and subjective GD, whereas social and legal indicators of GD showed a significant increase across time; and 4) among body changes induced by CHT, only breast development and increased body mass index had a significant impact on psychopathology reduction across time in male to female subjects and female to male subjects, respectively. CONCLUSIONS:The aforementioned results support the efficacy of CHT intervention in improving subjective perception of oneʼs own body, which was partially associated with objective changes.
Author Amato, Anna Maria Letizia
Maggi, Mario
Fanni, Egidia
Cassioli, Emanuele
Sensi, Carolina
Fisher, Alessandra D.
Casale, Helen
Mosconi, Maddalena
Ricca, Valdo
Dèttore, Davide
Bettini, Eva
Castellini, Giovanni
Ristori, Jiska
AuthorAffiliation Department of Experimental, Clinical, and Biomedical Sciences (A.D.F., G.C., J.R., P.H.C., E.C., C.S., E.F., A.M.L.A., E.B., M.Ma.), Sexual Medicine and Andrology Unit; Psychiatry Unit, Department of Neuroscience, Psychology, Drug Research and Child Health (V.R., G.C., E.C., C.S.), Department of Health Sciences University of Florence (D.D.), 50121 Florence, Italy; and Gender Identity Development Service (M.Mo.), Hospital S. Camillo-Forlanini, 00152 Rome, Italy
AuthorAffiliation_xml – name: Department of Experimental, Clinical, and Biomedical Sciences (A.D.F., G.C., J.R., P.H.C., E.C., C.S., E.F., A.M.L.A., E.B., M.Ma.), Sexual Medicine and Andrology Unit; Psychiatry Unit, Department of Neuroscience, Psychology, Drug Research and Child Health (V.R., G.C., E.C., C.S.), Department of Health Sciences University of Florence (D.D.), 50121 Florence, Italy; and Gender Identity Development Service (M.Mo.), Hospital S. Camillo-Forlanini, 00152 Rome, Italy
Author_xml – sequence: 1
  givenname: Alessandra D.
  surname: Fisher
  fullname: Fisher, Alessandra D.
  email: afisher@unifi.it
  organization: 1Department of Experimental, Clinical, and Biomedical Sciences (A.D.F., G.C., J.R., P.H.C., E.C., C.S., E.F., A.M.L.A., E.B., M.Ma.), Sexual Medicine and Andrology Unit, 50121 Florence, Italy
– sequence: 2
  givenname: Giovanni
  surname: Castellini
  fullname: Castellini, Giovanni
  email: giovannicastellini78@hotmail.com
  organization: 1Department of Experimental, Clinical, and Biomedical Sciences (A.D.F., G.C., J.R., P.H.C., E.C., C.S., E.F., A.M.L.A., E.B., M.Ma.), Sexual Medicine and Andrology Unit, 50121 Florence, Italy
– sequence: 3
  givenname: Jiska
  surname: Ristori
  fullname: Ristori, Jiska
  email: jiskaristori@libero.it
  organization: 1Department of Experimental, Clinical, and Biomedical Sciences (A.D.F., G.C., J.R., P.H.C., E.C., C.S., E.F., A.M.L.A., E.B., M.Ma.), Sexual Medicine and Andrology Unit, 50121 Florence, Italy
– sequence: 4
  givenname: Helen
  surname: Casale
  fullname: Casale, Helen
  email: helencasale@libero.it
  organization: 1Department of Experimental, Clinical, and Biomedical Sciences (A.D.F., G.C., J.R., P.H.C., E.C., C.S., E.F., A.M.L.A., E.B., M.Ma.), Sexual Medicine and Andrology Unit, 50121 Florence, Italy
– sequence: 5
  givenname: Emanuele
  surname: Cassioli
  fullname: Cassioli, Emanuele
  email: emanuele.cassioli@gmail.com
  organization: 1Department of Experimental, Clinical, and Biomedical Sciences (A.D.F., G.C., J.R., P.H.C., E.C., C.S., E.F., A.M.L.A., E.B., M.Ma.), Sexual Medicine and Andrology Unit, 50121 Florence, Italy
– sequence: 6
  givenname: Carolina
  surname: Sensi
  fullname: Sensi, Carolina
  email: carolina.sensi@gmail.com
  organization: 1Department of Experimental, Clinical, and Biomedical Sciences (A.D.F., G.C., J.R., P.H.C., E.C., C.S., E.F., A.M.L.A., E.B., M.Ma.), Sexual Medicine and Andrology Unit, 50121 Florence, Italy
– sequence: 7
  givenname: Egidia
  surname: Fanni
  fullname: Fanni, Egidia
  email: egidiafanny@hotmail.it
  organization: 1Department of Experimental, Clinical, and Biomedical Sciences (A.D.F., G.C., J.R., P.H.C., E.C., C.S., E.F., A.M.L.A., E.B., M.Ma.), Sexual Medicine and Andrology Unit, 50121 Florence, Italy
– sequence: 8
  givenname: Anna Maria Letizia
  surname: Amato
  fullname: Amato, Anna Maria Letizia
  email: annaml.amato@gmail.com
  organization: 1Department of Experimental, Clinical, and Biomedical Sciences (A.D.F., G.C., J.R., P.H.C., E.C., C.S., E.F., A.M.L.A., E.B., M.Ma.), Sexual Medicine and Andrology Unit, 50121 Florence, Italy
– sequence: 9
  givenname: Eva
  surname: Bettini
  fullname: Bettini, Eva
  email: eva.bettini.firenze@gmail.com
  organization: 1Department of Experimental, Clinical, and Biomedical Sciences (A.D.F., G.C., J.R., P.H.C., E.C., C.S., E.F., A.M.L.A., E.B., M.Ma.), Sexual Medicine and Andrology Unit, 50121 Florence, Italy
– sequence: 10
  givenname: Maddalena
  surname: Mosconi
  fullname: Mosconi, Maddalena
  email: maddalenamosconi@libero.it
  organization: 4Gender Identity Development Service (M.Mo.), Hospital S. Camillo-Forlanini, 00152 Rome, Italy
– sequence: 11
  givenname: Davide
  surname: Dèttore
  fullname: Dèttore, Davide
  email: davide.dettore@unifi.it
  organization: 3Department of Health Sciences University of Florence (D.D.), 50121 Florence, Italy
– sequence: 12
  givenname: Valdo
  surname: Ricca
  fullname: Ricca, Valdo
  email: valdo.ricca@unifi.it
  organization: 2Psychiatry Unit, Department of Neuroscience, Psychology, Drug Research and Child Health (V.R., G.C., E.C., C.S.), 50121 Florence, Italy
– sequence: 13
  givenname: Mario
  surname: Maggi
  fullname: Maggi, Mario
  email: m.maggi@dfc.unifi.it
  organization: 1Department of Experimental, Clinical, and Biomedical Sciences (A.D.F., G.C., J.R., P.H.C., E.C., C.S., E.F., A.M.L.A., E.B., M.Ma.), Sexual Medicine and Andrology Unit, 50121 Florence, Italy
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27700538$$D View this record in MEDLINE/PubMed
BookMark eNp1ks1P3DAQxa2KChbKrecqUg_lgKk_EjvhVm2hVEIqUhepPVmOMyHZOvbWTrTw3-OwcEHCF8uj35ux3_Mh2nPeAUIfKTmjjJKva3PGCBWYMineoQWt8gJLWsk9tCCEUVxJ9ucAHca4JoTmecH30QGTkpCClwvULYOPEf-G--zKhyG1zlYB9DiAGzPtmuwmPpjO1723_q432mbLTrs7iFnvEqldjHA_pfINhOhdPM9WW4__gg7ZpbfWb_HtJvuuR_0BvW-1jXD8vB-h28uL1fIKX__68XP57RobXgmBc8olrVuRXgCsaoUgknNNoW7asiEUSkLAgMmFbHXecNnUTOqylMyIihto-BE62fXdBP9_gjiqoY8GrNUO_BQVLXnBBWWVSOjnV-jaT8Gl2ylORc4lL8oiUZ-eqakeoFGb0A86PKgXDxPAdoCZrQzQKtOPeuy9G4PuraJEzUGptVFzUGoOKolOX4le-r6B5zt86-2YnP5npy0E1YG2Y6dIWsmREs8CStMJP1WS7MtO5qfNWwOePg5_BBBarlA
CitedBy_id crossref_primary_10_1002_nau_25097
crossref_primary_10_1002_cpt_2234
crossref_primary_10_1016_j_sleep_2023_04_028
crossref_primary_10_1210_er_2018_00011
crossref_primary_10_1038_s41366_023_01334_0
crossref_primary_10_1016_j_eprac_2023_03_003
crossref_primary_10_1016_j_jsxm_2022_03_215
crossref_primary_10_1089_trgh_2021_0061
crossref_primary_10_1210_jendso_bvab011
crossref_primary_10_7759_cureus_36484
crossref_primary_10_3390_jcm9113733
crossref_primary_10_1016_j_sexol_2020_09_003
crossref_primary_10_1016_j_jpag_2019_05_010
crossref_primary_10_1080_17446651_2020_1825075
crossref_primary_10_1007_s40618_017_0647_5
crossref_primary_10_3389_fendo_2021_717766
crossref_primary_10_1093_humrep_deaa254
crossref_primary_10_3389_fendo_2021_718200
crossref_primary_10_1016_j_yhbeh_2019_02_016
crossref_primary_10_1176_appi_ajp_2019_19010080
crossref_primary_10_1007_s10508_019_1396_7
crossref_primary_10_1089_trgh_2023_0186
crossref_primary_10_1007_s40618_022_01835_1
crossref_primary_10_1210_clinem_dgad729
crossref_primary_10_1007_s10508_018_1189_4
crossref_primary_10_1161_CIR_0000000000001003
crossref_primary_10_1038_s41443_023_00711_7
crossref_primary_10_3390_cancers15010245
crossref_primary_10_3238_arztebl_2020_0725
crossref_primary_10_1007_s13555_021_00574_0
crossref_primary_10_1097_SAP_0000000000002729
crossref_primary_10_1007_s13669_020_00298_6
crossref_primary_10_1111_ans_70028
crossref_primary_10_3389_fendo_2022_1059473
crossref_primary_10_1080_00207411_2019_1711328
crossref_primary_10_1210_jc_2017_01927
crossref_primary_10_1089_trgh_2020_0077
crossref_primary_10_1007_s00467_022_05445_0
crossref_primary_10_3390_jcm11071784
crossref_primary_10_1007_s11920_018_0973_0
crossref_primary_10_1016_j_jsxm_2021_01_185
crossref_primary_10_3389_bjbs_2024_12339
crossref_primary_10_5694_mja2_50259
crossref_primary_10_1016_j_beem_2022_101617
crossref_primary_10_3390_jcm10020296
crossref_primary_10_1016_j_cps_2018_03_003
crossref_primary_10_1007_s40618_016_0552_3
crossref_primary_10_1089_lgbt_2017_0034
crossref_primary_10_1016_j_beem_2024_101921
crossref_primary_10_1016_j_clindermatol_2025_02_010
crossref_primary_10_1093_asjof_ojad015
crossref_primary_10_1016_j_jaclp_2023_04_004
crossref_primary_10_1080_17425255_2020_1777278
crossref_primary_10_1093_jsxmed_qdac036
crossref_primary_10_1515_jpem_2023_0119
crossref_primary_10_1016_j_jcte_2020_100230
crossref_primary_10_1002_14651858_CD013138_pub2
crossref_primary_10_1007_s11930_024_00385_2
crossref_primary_10_1097_PRS_0000000000011325
crossref_primary_10_1016_j_jsxm_2019_10_008
crossref_primary_10_1371_journal_pone_0305059
crossref_primary_10_6118_jmm_22039
crossref_primary_10_3390_jcm10071454
crossref_primary_10_1210_jc_2018_01777
crossref_primary_10_1007_s11013_023_09838_0
crossref_primary_10_11124_JBISRIR_2017_003869
crossref_primary_10_1111_cen_13821
crossref_primary_10_3390_sexes2010009
crossref_primary_10_1016_j_jadohealth_2021_09_004
crossref_primary_10_1038_s41443_021_00490_z
crossref_primary_10_1016_j_fertnstert_2019_09_002
crossref_primary_10_1016_j_sxmr_2020_03_003
crossref_primary_10_1007_s10508_023_02787_0
crossref_primary_10_1097_AOG_0000000000002936
crossref_primary_10_1176_appi_ajp_2019_19111151
crossref_primary_10_1007_s11136_024_03664_6
crossref_primary_10_1016_j_jsxm_2019_05_009
crossref_primary_10_15406_emij_2024_12_00360
crossref_primary_10_1001_jamanetworkopen_2023_6425
crossref_primary_10_1089_trgh_2020_0094
crossref_primary_10_1097_GCO_0000000000000771
crossref_primary_10_3390_jcm9061609
crossref_primary_10_1016_j_ecl_2019_01_004
crossref_primary_10_1176_appi_ajp_2017_17060626
crossref_primary_10_1016_j_jsxm_2018_03_079
crossref_primary_10_3389_fpsyt_2024_1422333
crossref_primary_10_1007_s12020_024_03736_0
crossref_primary_10_1038_s41386_018_0140_7
crossref_primary_10_1097_PRA_0000000000000633
crossref_primary_10_1373_clinchem_2018_288241
crossref_primary_10_1186_s40337_023_00828_6
crossref_primary_10_61622_rbgo_2024rbgo33
crossref_primary_10_1111_cen_14140
crossref_primary_10_1080_14737167_2017_1388164
crossref_primary_10_1080_00918369_2020_1868185
crossref_primary_10_1016_j_bpobgyn_2022_102296
crossref_primary_10_1089_trgh_2023_0022
crossref_primary_10_3390_jcm9061731
crossref_primary_10_1016_j_jsxm_2019_10_021
crossref_primary_10_11124_JBIES_22_00066
crossref_primary_10_1016_j_ejogrb_2022_02_048
crossref_primary_10_1007_s40618_023_02251_9
crossref_primary_10_1001_jamanetworkopen_2023_31919
crossref_primary_10_1038_s41443_020_0323_8
crossref_primary_10_1186_s13023_021_02039_1
crossref_primary_10_3389_fendo_2024_1496160
crossref_primary_10_1016_j_jsxm_2020_01_012
crossref_primary_10_1016_j_psychres_2018_08_092
crossref_primary_10_1016_j_esxm_2017_06_004
crossref_primary_10_1016_j_cppeds_2019_100683
crossref_primary_10_1038_s41366_021_00935_x
crossref_primary_10_1111_andr_12382
crossref_primary_10_1016_j_jsxm_2019_12_020
crossref_primary_10_1080_09589236_2022_2092083
crossref_primary_10_1007_s40618_022_01944_x
crossref_primary_10_1007_s40618_021_01694_2
crossref_primary_10_1177_2042018819871166
crossref_primary_10_1210_clinem_dgaa841
crossref_primary_10_1016_j_cortex_2020_04_005
crossref_primary_10_1080_26895269_2024_2333525
crossref_primary_10_1111_joim_13441
crossref_primary_10_1177_20420188231178373
crossref_primary_10_1038_s41443_020_00402_7
crossref_primary_10_1542_peds_2019_3006
crossref_primary_10_1007_s40618_017_0629_7
crossref_primary_10_1016_j_psyneuen_2019_02_023
crossref_primary_10_1016_j_clbc_2018_12_006
crossref_primary_10_1016_j_mce_2017_08_008
crossref_primary_10_1038_s41562_023_01605_w
crossref_primary_10_1530_EC_22_0170
crossref_primary_10_1097_SAP_0000000000001855
crossref_primary_10_1089_trgh_2023_0040
crossref_primary_10_1007_s41975_021_00215_x
crossref_primary_10_1038_s41443_021_00427_6
crossref_primary_10_1093_jsxmed_qdad043
crossref_primary_10_1136_bmj_2021_069874
crossref_primary_10_1080_26895269_2022_2100644
crossref_primary_10_1089_lgbt_2022_0289
crossref_primary_10_1089_trgh_2021_0139
crossref_primary_10_1016_j_esxm_2018_11_005
crossref_primary_10_1210_clinem_dgab089
crossref_primary_10_1016_j_jsxm_2018_01_017
crossref_primary_10_1080_15532739_2019_1692750
crossref_primary_10_1016_j_jsxm_2018_03_083
crossref_primary_10_1210_clinem_dgae193
crossref_primary_10_1016_j_amepre_2020_03_026
crossref_primary_10_3390_ijms21062123
ContentType Journal Article
Copyright Copyright © 2016 by the Endocrine Society 2016
Copyright © 2016 by The Endocrine Society
Copyright © 2016 by the Endocrine Society
Copyright_xml – notice: Copyright © 2016 by the Endocrine Society 2016
– notice: Copyright © 2016 by The Endocrine Society
– notice: Copyright © 2016 by the Endocrine Society
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7T5
7TM
H94
K9.
7X8
DOI 10.1210/jc.2016-1276
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Calcium & Calcified Tissue Abstracts
Immunology Abstracts
Nucleic Acids Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
Calcium & Calcified Tissue Abstracts
Nucleic Acids Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE

AIDS and Cancer Research Abstracts
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1945-7197
EndPage 4269
ExternalDocumentID 27700538
10_1210_jc_2016_1276
00004678-201611000-00046
10.1210/jc.2016-1276
Genre Journal Article
GroupedDBID ---
-~X
.55
.XZ
08P
0R~
18M
1TH
29K
2WC
34G
354
39C
4.4
48X
53G
5GY
5RS
5YH
8F7
AABZA
AACZT
AAIMJ
AAPQZ
AAPXW
AARHZ
AAUAY
AAVAP
AAWTL
ABBLC
ABDFA
ABEJV
ABGNP
ABJNI
ABLJU
ABMNT
ABNHQ
ABOCM
ABPMR
ABPPZ
ABPQP
ABPTD
ABQNK
ABVGC
ABWST
ABXVV
ACGFO
ACGFS
ACPRK
ACUTJ
ACYHN
ADBBV
ADGKP
ADGZP
ADHKW
ADQBN
ADRTK
ADVEK
AELWJ
AEMDU
AENEX
AENZO
AETBJ
AEWNT
AFCHL
AFFZL
AFGWE
AFOFC
AFRAH
AFXAL
AGINJ
AGKRT
AGQXC
AGUTN
AHMBA
AHMMS
AJEEA
ALMA_UNASSIGNED_HOLDINGS
APIBT
ARIXL
ASPBG
ATGXG
AVWKF
AZFZN
BAWUL
BAYMD
BCRHZ
BEYMZ
BSWAC
BTRTY
C45
CDBKE
CS3
D-I
DAKXR
DIK
E3Z
EBS
EJD
EMOBN
ENERS
F5P
FECEO
FHSFR
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
GX1
H13
HZ~
H~9
KBUDW
KOP
KQ8
KSI
KSN
L7B
M5~
MHKGH
MJL
N9A
NLBLG
NOMLY
NOYVH
NVLIB
O9-
OAUYM
OBH
OCB
ODMLO
OFXIZ
OGEVE
OHH
OJZSN
OK1
OPAEJ
OVD
OVIDX
P2P
P6G
REU
ROX
ROZ
TEORI
TJX
TLC
TR2
TWZ
VVN
W8F
WOQ
X7M
YBU
YFH
YHG
YOC
YSK
ZY1
~02
~H1
.GJ
3O-
7X7
88E
8FI
8FJ
AAJQQ
AAKAS
AAPGJ
AAQQT
AAUQX
AAWDT
AAYJJ
ABDPE
ABUWG
ABXZS
ACFRR
ACVCV
ACZBC
ADMTO
ADNBA
ADZCM
AEMQT
AEOTA
AERZD
AFFNX
AFFQV
AFKRA
AFYAG
AGMDO
AGORE
AHGBF
AI.
AJBYB
AJDVS
ALXQX
APJGH
AQDSO
AQKUS
AVNTJ
BENPR
BPHCQ
BVXVI
CCPQU
EIHJH
FEDTE
FYUFA
HMCUK
HVGLF
IAO
IHR
INH
ITC
J5H
M1P
MBLQV
N4W
NU-
OBFPC
PHGZM
PHGZT
PQQKQ
PROAC
PSQYO
TMA
UKHRP
VH1
WHG
X52
ZGI
ZXP
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7T5
7TM
H94
K9.
7X8
ID FETCH-LOGICAL-c3966-41371bf6719e29f660733a1ebdf8d01e800ecec467fa4d37db27a8872c693ced3
ISSN 0021-972X
IngestDate Fri Jul 11 02:39:51 EDT 2025
Mon Jun 30 12:42:29 EDT 2025
Thu Apr 03 06:57:12 EDT 2025
Tue Jul 01 01:10:42 EDT 2025
Thu Apr 24 23:10:09 EDT 2025
Fri May 16 03:43:11 EDT 2025
Fri Feb 07 10:35:30 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 11
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c3966-41371bf6719e29f660733a1ebdf8d01e800ecec467fa4d37db27a8872c693ced3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 27700538
PQID 3164373585
PQPubID 2046206
PageCount 10
ParticipantIDs proquest_miscellaneous_1835361296
proquest_journals_3164373585
pubmed_primary_27700538
crossref_citationtrail_10_1210_jc_2016_1276
crossref_primary_10_1210_jc_2016_1276
wolterskluwer_health_00004678-201611000-00046
oup_primary_10_1210_jc_2016-1276
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20161101
2016-November
2016-11-00
PublicationDateYYYYMMDD 2016-11-01
PublicationDate_xml – month: 11
  year: 2016
  text: 20161101
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Washington
PublicationTitle The journal of clinical endocrinology and metabolism
PublicationTitleAlternate J Clin Endocrinol Metab
PublicationYear 2016
Publisher Oxford University Press
Copyright by The Endocrine Society
Publisher_xml – name: Oxford University Press
– name: Copyright by The Endocrine Society
SSID ssj0014453
Score 2.5683193
Snippet Context:To date, there are few studies investigating the impact of body changes induced by cross-sex hormonal treatment (CHT) on psychobiological well-being in...
CONTEXT:To date, there are few studies investigating the impact of body changes induced by cross-sex hormonal treatment (CHT) on psychobiological well-being in...
To date, there are few studies investigating the impact of body changes induced by cross-sex hormonal treatment (CHT) on psychobiological well-being in...
CONTEXTTo date, there are few studies investigating the impact of body changes induced by cross-sex hormonal treatment (CHT) on psychobiological well-being in...
SourceID proquest
pubmed
crossref
wolterskluwer
oup
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 4260
SubjectTerms Adult
Anthropometry
Body Image - psychology
Body mass index
Breast
Cross-Sectional Studies
Depression - psychology
Female
Females
Follow-Up Studies
Gender
Gender Dysphoria - drug therapy
Gender Dysphoria - psychology
Gonadal Steroid Hormones - administration & dosage
Gonadal Steroid Hormones - pharmacology
Humans
Male
Mental depression
Middle Aged
Personal Satisfaction
Psychobiology
Psychopathology
Sex hormones
Temporal perception
Transsexualism - psychology
Title Cross-Sex Hormone Treatment and Psychobiological Changes in Transsexual Persons: Two-Year Follow-Up Data
URI https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00004678-201611000-00046
https://www.ncbi.nlm.nih.gov/pubmed/27700538
https://www.proquest.com/docview/3164373585
https://www.proquest.com/docview/1835361296
Volume 101
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKkBAIIe4UBjISPFWemjiXhrdpYwzQeKGVxlPk2I4oK8m0tCriJ_KrOMd2XXfqxOUlqhondX2-nEt8zncIeQUWpFBDlbKoqBUEKDVnIqoTJEJOqjwRfKTwhf7Jp-x4knw4TU97vV9B1tJiXu3Jn1vrSv5HqvAdyBWrZP9Bsv6m8AV8BvnCESQMx7-S8QGaOPZZ_xgcg-vZgr843sgbt9rN8iwZYdhaApMCa4xUZwiXTRo8zNG8al-27AuS-xwBQNolm5wDMOYi9GERWQHhhK-t1I1qQQc1a1an73oOGJutWApF2Gl9f4bNVxp1IQaHe-udkM4whJo-U4N3mCjbNFO_KWQpTQzwpt2ZCK5yWdHGiIYvMqLMVfT5sHd7gWSovDGbJDfd18F0WX1dJCnLI5vi6xW6u6tDbhToZ-TjD2w91vFutSMQCKMdQY5LnGicX6LrdvHTtoHXyPUYQhbspnH4_qPf0UoSx4jq_oQrwsAKqvDqDfdoo-QyiHxukdvLFpMpujNTSxF4ROO75I4LZei-xeU90tPNfXLjxCVrPCBfPTypgyf18KQgeXoZntTBk04bGsCTOni-oStwUg9OiuB8SCZHb8cHx8w19mCSQ3jNwHHKo6rOQHA6Luosw86hItKVqkdqGGkIYrTUEmx4LRLFc1XFuQBrGMus4FIr_ojsNDDrJ4RCuJ0mcC6upcQi8lGVCnB6Cy2zEZdD3ieD1XqW0rHeY_OVWYnRL6x--U2WuPolrn6fvPajzy3byxXjKIjmqiHMDtldya10z2RX8gj3yTmE6H3y0p8GhY67dKLR7aIrwcamHOKOAm7x2Mrb_xAAC63mqE_YBgBKWzRdmogf3E-G00AySMsakT3983yfkZvrh3KX7MwvFvo5-Nvz6oUB8m8kFtFC
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cross-Sex+Hormone+Treatment+and+Psychobiological+Changes+in+Transsexual+Persons%3A+Two-Year+Follow-Up+Data&rft.jtitle=The+journal+of+clinical+endocrinology+and+metabolism&rft.au=Fisher%2C+Alessandra+D.&rft.au=Castellini%2C+Giovanni&rft.au=Ristori%2C+Jiska&rft.au=Casale%2C+Helen&rft.date=2016-11-01&rft.pub=Oxford+University+Press&rft.issn=0021-972X&rft.eissn=1945-7197&rft.volume=101&rft.issue=11&rft.spage=4260&rft.epage=4269&rft_id=info:doi/10.1210%2Fjc.2016-1276&rft.externalDocID=10.1210%2Fjc.2016-1276
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-972X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-972X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-972X&client=summon